kabutan

Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.

Fri Feb 14, 2025 5:00 pm JST Earnings

4893 Noile-Immune Biotech Inc. 【J-GAAP】

Earnings Report

Noile-Immune Biotech Inc. <4893> [TSE Growth] announced its financial results after the market closed on February 14th (17:00). The ordinary loss (non-consolidated) for the fiscal year ending December 2024 was loss of 962 million yen, a reduction in the deficit compared to loss of 962 million yen in the previous term. This marks the fifth consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2025.

In the most recent three-month period, from October to December (4Q), the ordinary loss improved to a deficit of 177 million yen (compared to a loss of 279 million yen in the same period last year). The operating profit/loss margin improved from -14000.0% in the same period last year to -8850.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 316 -775 -1,127 -1,130 -27.3 0 Feb 13, 2024 J-GAAP
Dec, 2024 7 -1,069 -962 -964 -22.3 0 Feb 14, 2025 J-GAAP
YoY -97.8% -37.9% +14.6% +14.7% +18.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 7 -1,099 -991 -994 -23.0 0 Nov 14, 2024 J-GAAP
Dec, 2024 Results 7 -1,069 -962 -964 -22.3 0 Feb 14, 2025 J-GAAP
Revision Rate 0.0% +2.7% +2.9% +3.0% +3.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 2 -681 -682 -683 -15.8 0 Aug 9, 2024 J-GAAP
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 316 -775 -1,127 -1,130 -27.3 0 Feb 13, 2024 J-GAAP
Dec, 2024 7 -1,069 -962 -964 -22.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 2 -280 -279 -280 -6.8 -14,000.0 Feb 13, 2024 J-GAAP
Jan - Mar, 2024 2 -339 -339 -340 -7.9 -16,950.0 May 14, 2024 J-GAAP
Apr - Jun, 2024 0 -342 -343 -343 -7.9 -Inf Aug 9, 2024 J-GAAP
Jul - Sep, 2024 3 -211 -103 -104 -2.4 -7,033.3 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 2 -177 -177 -177 -4.1 -8,850.0 Feb 14, 2025 J-GAAP
YoY 0.0% +36.8% +36.6% +36.8% +39.4%

Related Articles